InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,411.15
(
-1.53%
)
Post# of 252499
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

miljenko

Send PM Follow Ignore
Followers 4
Posts 313
Boards Moderated 0
Alias Born 11/21/2011

miljenko

Re: None

Saturday, 07/18/2020 12:14:21 PM

Saturday, July 18, 2020 12:14:21 PM

Post# of 252499
mRNA v Oxford (Ad)
Some compare today Oxford CoV2 vaccine to MERS-one (in rhesus macaques, as failed), and to current CoV2 animal data:
https://pubmed.ncbi.nlm.nih.gov/28579232/ (mice)
https://pubmed.ncbi.nlm.nih.gov/29739720/ (mice)
https://pubmed.ncbi.nlm.nih.gov/32577525/

And, new article on T-cells response in CoV2 infected:
https://science.sciencemag.org/content/early/2020/07/15/science.abc8511

So, it is way too complex to extrapolate animal data to predict effectiveness of the particular vaccine, as well as any early P1 healthy volunteer data (elder population may be more helpful) from nAbs & T-cells response.

Monday Oxford data may just be another point of conflict?



Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up